Cargando…
Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries
The long duration of TB therapy, the high prevalence of HIV coinfection, and the growing prevalence of drug-resistant TB underscore the urgent need for more effective treatments.
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062480/ https://www.ncbi.nlm.nih.gov/pubmed/17988170 http://dx.doi.org/10.1371/journal.pmed.0040302 |